Takeda acquires rights to new “Trojan horse” celiac antidote in US$420m deal

Takeda acquires rights to new “Trojan horse” celiac antidote in US$420m deal

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

04 Dec 2019 --- Early introduction to allergenic foods, such as eggs and peanuts, has been found to be effective in preventing the development of food allergies in specific groups... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

15 Nov 2019 --- In the same way that Beyond Meat has disrupted traditional vegan burgers and meat alternatives, Unbun Foods is poised to disrupt the traditional bakery industry... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

08 Nov 2019 --- Allergy symptoms can range anywhere from annoying to painful to deadly. Therefore, industry is called upon to seek out the best methods to prevent allergies and... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

05 Nov 2019 --- Research from the National Institutes of Health (NIH), a US medical research agency, has revealed that sesame allergy is becoming increasingly common among... Read More

FormattedPicture

PACKAGING & TECHNOLOGY NEWS

23 Oct 2019 --- Responding to the steady increase in demand for non-allergen ingredients, EHL Ingredients has overhauled production processes to completely segregate lines for... Read More

trans